FDA-Drug2026-07-29Class IIMISBRANDING
Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotency
What this means
Major Pharmaceuticals is recalling one lot of levothyroxine sodium 150 mcg tablets because they do not contain the full stated dose of active ingredient. Patients taking this medication need the correct dose to manage their thyroid condition properly.
- Check if you have levothyroxine tablets from Major Pharmaceuticals with lot #N02167 and expiration date 07/2026 (NDC 0904-6956-61)
- Contact your pharmacy or doctor if you have this lot
- Do not stop taking your levothyroxine without talking to your doctor first
The agency's original wording
Hazard
Subpotent Drug
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6956-61
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0706-2026More Major Pharmaceuticals recalls
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotent drug
- FDA-Drug2026-07-29Major Pharmaceuticals Levothyroxine Sodium 112 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine 25 mcg tablets recalled for subpotency
- FDA-Drug2026-07-29Major Pharmaceuticals levothyroxine sodium tablets recalled for subpotent drug
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.